Women’s Health World Congress

Physicians are uniquely positioned to identify unmet clinical needs—but translating those insights into viable, high-impact business opportunities requires a distinct set of strategic, operational, and entrepreneurial skills. In this interactive workshop, Theresa Neil, founder of FEMOVATE, guides clinicians through the process of translating clinical insight into sustainable innovation. 

This session will explore how to evaluate ideas through clinical, market, and feasibility lenses; assess unmet needs in women’s health; and determine where innovation can create meaningful patient- and system-level impact. Participants will gain practical tools to shape concepts, understand pathways to validation, and navigate early-stage considerations, including partnerships, funding, and implementation, within healthcare environments. Through guided discussion and real-world examples, attendees will leave with a clearer framework for transforming clinical expertise into scalable solutions. This workshop is ideal for physicians interested in entrepreneurship, innovation leadership, and creating new care models, technologies, or services that advance women’s health and deliver measurable impact. 

• Identify unmet clinical needs in women’s health that present viable opportunities for innovation.

• Evaluate clinical ideas using market, feasibility, and impact-based frameworks.

• Apply practical strategies for early validation, partnerships, and implementation within healthcare systems.

Despite advances in clinical care and innovation, reimbursement inequities remain one of the most significant—and least openly addressed—barriers in women’s health. In this candid session, Louise King, MD, JD, and Christopher Robertson, JD, examine the history of systemic reimbursement disparities that undervalue women’s healthcare services and the legal frameworks that sustain them.

Drawing on clinical, policy, and legal expertise, the speakers explore how payment structures, coding practices, and coverage decisions disproportionately affect women’s health specialties and procedures. The session unpacks how these inequities shape access to care, clinical innovation, workforce sustainability, and health outcomes, while examining the legal and regulatory implications for providers and health systems. Attendees will leave with a clearer understanding of where reimbursement inequities originate.

• Describe the historical and structural drivers of reimbursement inequities in women’s health.

• Examine how payment and coding structures affect access, innovation, and workforce sustainability.

• Identify legal, regulatory, and policy levers that may help address reimbursement disparities.

As women’s healthcare evolves toward more integrated, patient-centered models, academic health systems are uniquely positioned to lead meaningful transformation. In this fireside chat, Caren Behar, MD, and Dana Gossett, MD, share insights from the Tisch Center for Women’s Health and explore how coordinated, comprehensive care models can redefine the future of women’s healthcare.

Through a candid discussion, Drs. Behar and Gossett examine the Tisch Center’s multidisciplinary approach—integrating clinical care, research, education, and innovation to address women’s health needs across the lifespan. The conversation highlights lessons learned in building collaborative teams, aligning specialties, and designing care pathways that improve access, outcomes, and the patient experience.

• Explain the core elements of a comprehensive, multidisciplinary women’s health model.

• Assess strategies for aligning clinical care, research, and education within integrated systems.

• Identify lessons learned that can inform implementation in other health systems.

Impostor phenomenon is often framed as an individual confidence issue, yet it is frequently produced and reinforced by the systems in which professionals work. This session examines how organizational structures, cultural norms, and systemic inequities shape persistent self-doubt, particularly for women and underrepresented groups in healthcare and academic medicine. Participants will reframe impostor feelings through a systems lens and explore evidence-based strategies at the individual, team, and institutional levels to foster inclusion, psychological safety, and sustainable leadership confidence.

• Describe how organizational structures, culture, and systemic inequities contribute to the development and persistence of impostor phenomenon in healthcare and professional environments.
• Differentiate individual-level narratives of self-doubt from system-driven factors that disproportionately affect women and underrepresented groups in leadership and academic medicine.
• Identify evidence-based strategies at the individual, team, and institutional levels to mitigate impostor phenomenon and promote inclusive, psychologically safe workplaces

The Rapid-Fire Session delivers sharp, high-impact insight into the digital innovations reshaping women’s health. Through fast-paced, idea-driven talks, presenters will spotlight technologies and strategies already improving access, care experiences, and outcomes for women.

The session concludes with a focused interactive discussion, followed by dedicated networking time to continue conversations and connect directly with presenters.

• Identify high-impact digital innovations transforming women’s health care delivery

• Assess real-world opportunities and challenges related to adoption, equity, and scale

• Apply practical considerations for integrating digital solutions into clinical workflows

Menopause care is undergoing a long-overdue transformation, driven by new evidence, updated guidelines, and growing patient demand for informed, personalized treatment options. In this timely session, Dana Gossett, MD, examines the evolving landscape of menopause management with a focused look at the resurgence and refinement of hormone therapy. Dr. Gossett will review current evidence on the benefits, risks, and appropriate use of hormone therapy, clarifying misconceptions that have shaped clinical practice for decades. The session will address timing, formulation options, and counseling strategies, while also highlighting how menopause intersects with cardiovascular, metabolic, bone, and mental health. This session equips attendees with practical, evidence-based insights to confidently navigate menopause care and respond to patient questions.

• Review current evidence guiding hormone therapy use in menopause management.

• Differentiate risks, benefits, and appropriate patient selection for hormone therapy.

• Apply evidence-based counseling strategies to address patient concerns and misconceptions.

As artificial intelligence becomes increasingly embedded in clinical decision-making, its ethical application is especially critical in women’s health—where historical underrepresentation, data bias, and structural inequities persist. In this session, Dr. King brings a rare dual perspective as a surgeon, legal expert, and academic leader to examine how clinical AI can be deployed responsibly to advance equitable, evidence-based care for women. Drawing on real-world clinical and research examples, she will address how algorithmic design, data sources, and validation processes can either reinforce disparities or help close longstanding gaps in diagnosis, treatment, and outcomes. Robertson will add context from FDA law,  hospital accreditors, bioethics of consent and disclosure, and empirical evidence from the literature.

Learning Objectives

1. Identify ethical risks associated with AI use in women’s healthcare.

2. Examine how data bias and algorithmic design impact clinical decision-making.

3. Apply principles for responsible, equitable AI deployment in clinical settings.

Clinicians are being asked to do more than ever in a healthcare system that grows more complex by the day, while women’s health continues to suffer from research gaps and systemic bias. Meanwhile, patients are arriving with data, charts, and questions shaped by unprecedented access to information. This session invites an honest, respectful conversation about how strategy and innovation can help bridge these realities. Rather than dismissing data-informed patients or speaking down to clinicians, we’ll explore how shared understanding, education, and collaboration can strengthen care and improve outcomes in women’s health.

Learning Objectives

1. Examine how strategic innovation can address persistent gaps in women’s healthcare.

2. Identify frameworks for aligning technology, partnerships, and patient-centered design.

3. Apply consumer and systems insights to develop scalable women’s health solutions.

Metabolic health is foundational to women’s well-being, yet it remains underrecognized and undertreated across the healthcare continuum. In this session, Caren Behar, MD, brings clinical and leadership perspective to examine why women’s metabolic health represents a critical—and often overlooked—imperative in modern care delivery. Dr. Behar will explore how conditions such as insulin resistance, obesity, metabolic syndrome, and their intersections with reproductive health, menopause, cardiovascular disease, and mental health uniquely affect women. The session will address gaps in screening, fragmented care models, and gender-based differences in risk assessment that contribute to delayed diagnosis and suboptimal outcomes. This session underscores the need for integrated, proactive approaches that improve long-term outcomes and advance equity in women’s health.

Learning Objectives

1. Describe how metabolic conditions uniquely impact women across the lifespan.

2. Identify gaps in screening and risk assessment for women’s metabolic health.

3. Apply integrated approaches to improve metabolic outcomes and long-term health.

Cardiovascular disease remains the leading cause of death for women, yet structural bias in research, diagnosis, and treatment continues to contribute to delayed care and poorer outcomes. In this timely session, Alexandra Kharazi, MD, FACS, cardiothoracic surgeon, examines how systemic and clinical biases shape women’s cardiovascular health—and what it will take to dismantle them. Dr. Kharazi will explore how historical underrepresentation of women in cardiovascular research, sex-based differences in symptom presentation, and entrenched care pathways influence clinical decision-making. Through a clinical and systems-level lens, she will highlight where bias most often appears—from diagnostic algorithms and referral patterns to surgical access and post-operative care—and how these factors impact patient outcomes. 

Learning Objectives

1. Identify structural and clinical biases affecting women’s cardiovascular care.

2. Examine sex-based differences in presentation, diagnosis, and treatment.

3. Evaluate strategies to reduce bias and improve cardiovascular outcomes for women.

Whole Brain Living, pioneered by Jill Bolte Taylor, PhD, former Harvard neuroscientist famous for having a full left hemispheric stroke, New York Time’s Bestselling Author and Time 100’s Most Influential People – is skyrocketing internationally into becoming the most powerful framework for amplifying and elevating leadership on all levels – especially for women in healthcare. Join Dr. Tammie Chang, Co-Founder of Pink Coat, MD, practicing board-certified pediatric oncologist and pediatric hospitalist, award-winning author, TEDx speaker, leadership coach, Healthcare Well-Being Leader, and fierce national advocate for gender equity and cultural change in healthcare, to advance your leadership skills to the next level! 

Learning Objectives: 

1. Identify the principles of Whole Brain Living in your own life and leadership. 
2. Recognize Whole Brain Living and its applications in healthcare leadership. 
3. Apply Whole Brain Living in specific real-world situations within your own leadership.